At the tenth anniversary of the month that the Renewable Fuel Standard was signed into law, the program has displaced nearly 1.9 billion barrels of foreign oil and consequently saved 589.33 million metric tons of U.S. transportation-related carbon emissions. The reduction is equivalent to removing more than 124 million cars from the road over the decade.

EPA’s delays in RFS rulemaking over the past two years have chilled necessary investment in advanced and cellulosic biofuels just as they reached commercial deployment. We estimate the industry has experienced a $13.7 billion shortfall in investment as a result.

BIO and the Association of Biotechnology Led Enterprises (ABLE) have released a new report, entitled Accelerating Growth: Forging India’s Bioeconomy, which present recommendations in support the growth of the country’s bioeconomy.

At a time when the global economy struggles to recover from a severe recession and uncertainty remains regarding future economic growth, bioscience industry development is generating significant attention both globally and at home.

Using an input output “I-O” approach to estimating the economic impact of academic licensing, and summing over the 15 years of available data for academic U.S. AUTM Survey respondents, the total contribution of these academic licensors to gross industry output ranges from $199B to $836B, in 2005 $US Dollars; contributions to GDP range from $86B to $338B, in 2005 $US Dollars.

This report examines the role played by IPRs in both upstream and downstream phases of the research, development and commercialization of biotechnology products and provides a review and analysis of the existing body of knowledge concerning the role of IPRs.